Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura.
about
Rituximab for children with immune thrombocytopenia: a systematic review.Rituximab-induced serum sickness in refractory immune thrombocytopenic purpura.Long-term follow-up of children with refractory immune thrombocytopenia treated with rituximab.A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study.Inhibitory human antichimeric antibodies to rituximab in a patient with pemphigusRituximab for autoimmune blistering diseases: recent studies, new insights.Ofatumumab treatment in lupus nephritis patients.Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitisConstruction and expression of a human/mouse chimeric CD19 monoclonal antibody: Successful modification of a murine IgM to a chimeric IgG.Rituximab in immunologic glomerular diseases.Formation, clearance, deposition, pathogenicity, and identification of biopharmaceutical-related immune complexes: review and case studies.Humanization of chimeric anti-CD20 antibody by logical and bioinformatics approach with retention of biological activity.Serum sickness with refractory nephrotic syndrome following treatment with rituximab.Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice
P2860
Q33401605-3E9569CF-FAD0-48BD-AE6C-35AF35ACCD28Q33402069-1C9D6498-6AA7-43FB-BB83-EAEEE4FDE944Q33413781-A21D40CA-9AC1-4029-BCAF-DA05EFE53F3FQ36088887-4DEA0609-D3BC-4D5F-B19E-FE5542E93BAFQ36140831-BDADB52E-F103-4E51-B15A-894DC240F2C3Q36751954-10825433-6F23-4CC3-9F25-945CC8790823Q37119045-C74510F3-5A45-485D-AA7E-74D0A6D373F7Q37640836-4FE6A5D5-9E79-4B61-B062-B2852761D593Q37652075-8823EE65-07FC-4FCB-9CF2-AF27E8573004Q37989298-D05CCC61-E5D9-4334-B46A-9573925B9C11Q38202541-038E2EBF-1A41-49C1-BF52-E810A602920DQ38735872-5070639F-38BB-4710-9EC0-638E777D358DQ50154996-B5614ACA-8C66-4849-991B-85A237D68298Q59137473-ECCF0AF8-0410-4DBE-88AD-195DABAF6508
P2860
Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Serum sickness with an elevate ...... mune thrombocytopenic purpura.
@ast
Serum sickness with an elevate ...... mune thrombocytopenic purpura.
@en
type
label
Serum sickness with an elevate ...... mune thrombocytopenic purpura.
@ast
Serum sickness with an elevate ...... mune thrombocytopenic purpura.
@en
prefLabel
Serum sickness with an elevate ...... mune thrombocytopenic purpura.
@ast
Serum sickness with an elevate ...... mune thrombocytopenic purpura.
@en
P2093
P1476
Serum sickness with an elevate ...... mmune thrombocytopenic purpura
@en
P2093
Hiroaki Goto
Hiromi Kato
Hiroyuki Takahashi
Osamu Sekiguchi
Shoko Goto
P2888
P304
P356
10.1007/S12185-009-0269-6
P577
2009-03-24T00:00:00Z
P6179
1033505056